---
figid: PMC5470118__nihms849851f3
figtitle: Canonical cannabinoid receptor (CBR)-mediated, G protein-dependent signaling
  pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5470118
filename: nihms849851f3.jpg
figlink: /pmc/articles/PMC5470118/figure/F3/
number: F3
caption: Schematic representation of canonical cannabinoid receptor (CBR)-mediated,
  G protein-dependent signaling pathways. Upon activation, CBRs preferentially couple
  to Gi/o-type G proteins and activate a series of downstream signaling cascades through
  which adenylyl cyclase (AC) is inhibited and mitogen-activated kinase (MAK) and
  extracellular kinase-1 and -2 (ERK1/2) are activated. Through the G-protein Gβγ
  subunit, CB1R activation can stimulate phospholipase C (PLC), leading to an increase
  in intracellular Ca2+ and activation of protein kinase C (PKC). Through Gi/o αβγ,
  the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of
  rapamycin (mTOR) intracellular signaling pathway can be stimulated. In addition,
  CB1R also modulates N- and P/Q-type voltage-gated Ca2+ channels, A-type and inward-rectifying
  K+ channels (GIRKs), and the sphingosine 1 receptor (S1PR) through which ceramide
  levels are regulated. These cell signaling circuits can modulate such diverse functions
  as neurite growth, cell proliferation and differentiation and inflammation and can
  also control gene transcription.
papertitle: 'Functional selectivity at G-protein coupled receptors: Advancing cannabinoid
  receptors as drug targets.'
reftext: Srikrishnan Mallipeddi, et al. Biochem Pharmacol. ;128:1-11.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.945749
figid_alias: PMC5470118__F3
figtype: Figure
redirect_from: /figures/PMC5470118__F3
ndex: 63618f02-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5470118__nihms849851f3.html
  '@type': Dataset
  description: Schematic representation of canonical cannabinoid receptor (CBR)-mediated,
    G protein-dependent signaling pathways. Upon activation, CBRs preferentially couple
    to Gi/o-type G proteins and activate a series of downstream signaling cascades
    through which adenylyl cyclase (AC) is inhibited and mitogen-activated kinase
    (MAK) and extracellular kinase-1 and -2 (ERK1/2) are activated. Through the G-protein
    Gβγ subunit, CB1R activation can stimulate phospholipase C (PLC), leading to an
    increase in intracellular Ca2+ and activation of protein kinase C (PKC). Through
    Gi/o αβγ, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian
    target of rapamycin (mTOR) intracellular signaling pathway can be stimulated.
    In addition, CB1R also modulates N- and P/Q-type voltage-gated Ca2+ channels,
    A-type and inward-rectifying K+ channels (GIRKs), and the sphingosine 1 receptor
    (S1PR) through which ceramide levels are regulated. These cell signaling circuits
    can modulate such diverse functions as neurite growth, cell proliferation and
    differentiation and inflammation and can also control gene transcription.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ca
  - ac
  - grk
  - Arr2
  - Galphai
  - mthl5
  - Rap1
  - norpA
  - sl
  - Plc21C
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Dsor1
  - Mtk
  - Raf
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - rl
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Mtor
  - Tor
  - Src42A
  - Csk
  - Src64B
  - CrebB
  - CrebA
  - Jra
  - AP-1gamma
  - kay
  - Dif
  - dl
  - Rel
  - CBR1
  - CNR1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - GRK1
  - GRK4
  - GRK5
  - GRK6
  - GRK7
  - GRK2
  - GRK3
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MTOR
  - SRC
  - FGR
  - FYN
  - YES1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - JUN
  - FOS
  - FOSB
  - JUNB
  - JUND
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - STAT3
  - Cancer
---
